We are live on ! Find out more
BPTH

Bio-Path Holdings Inc

Delisted

BPTH was delisted on the 18th of February, 2025.

23 hedge funds and large institutions have $2.24M invested in Bio-Path Holdings Inc in 2018 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

18% less capital invested

Capital invested by funds: $2.73M → $2.24M (-$492K)

21% less funds holding

Funds holding: 2923 (-6)

67% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 9

Holders
23
Holders Change
-6
Holders Change %
-20.69%
% of All Funds
0.53%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
3
Increased
7
Reduced
5
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UOTTAIMCU
1
University of Texas/Texas AM Investment Management Co (UTIMCO)
Texas
$766K
Vanguard Group
2
Vanguard Group
Pennsylvania
$467K +$84.2K +108 +23%
Renaissance Technologies
3
Renaissance Technologies
New York
$273K +$133K +171 +100%
SM
4
Sabby Management
Florida
$170K -$191K -245 -53%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$104K
Commonwealth Equity Services
6
Commonwealth Equity Services
Massachusetts
$88K -$3.12K -4 -3%
RCA
7
Rowland Carmichael Advisors
Arizona
$88K
Northern Trust
8
Northern Trust
Illinois
$57K +$32K +41 +132%
LTFS
9
Ladenburg Thalmann Financial Services
Florida
$41K
HighTower Advisors
10
HighTower Advisors
Illinois
$34K +$21.8K +28 +187%
RJFSA
11
Raymond James Financial Services Advisors
Florida
$30K
California Public Employees Retirement System
12
California Public Employees Retirement System
California
$23K
Goldman Sachs
13
Goldman Sachs
New York
$23K +$19.5K +25 +833%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$21K -$3.12K -4 -13%
UBS Group
15
UBS Group
Switzerland
$16K +$8.57K +11 +110%
BlackRock
16
BlackRock
New York
$13K -$3.12K -4 -20%
CAPTRUST Financial Advisors
17
CAPTRUST Financial Advisors
North Carolina
$9K +$10.1K +13 New
MAM
18
Meeder Asset Management
Ohio
$4K +$2.34K +3 +150%
GRP
19
Global Retirement Partners
California
$3K
Wells Fargo
20
Wells Fargo
California
$3K
AF
21
Advisornet Financial
Minnesota
$2K +$1.56K +2 New
Bank of America
22
Bank of America
North Carolina
$1K -$780 -1 -50%
BNP Paribas Financial Markets
23
BNP Paribas Financial Markets
France
$4
AFM
24
Anson Funds Management
Texas
-$272K -336 Closed
Hudson Bay Capital Management
25
Hudson Bay Capital Management
Connecticut
-$157K -194 Closed

BPTH Hedge Fund Activity: Q1 2018 in Review

23 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q1 2018, worth a combined $2.24M — down 18% from $2.73M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of BPTH and 3 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was Renaissance Technologies, adding an estimated $133K. The largest seller was Anson Funds Management, exiting entirely with an estimated $272K sold.

  • 23 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q1 2018, down from 29 in Q4 2017.
  • Funds reported $2.24M of Bio-Path Holdings Inc stock for Q1 2018, down 18% quarter-over-quarter.
  • 3 funds opened new Bio-Path Holdings Inc positions in Q1 2018 and 9 closed out, a net change of -6 holders.
  • The largest Bio-Path Holdings Inc buyer in Q1 2018 was Renaissance Technologies, an estimated $133K added.
  • The largest Bio-Path Holdings Inc seller in Q1 2018 was Anson Funds Management, an estimated $272K sold.

Based on aggregated 13F filings for Q1 2018.